Profile
| Role | Director |
|---|---|
| Notability | 30/100 |
Updated Jul 16, 2026
Anderson Kenneth Carl has filed 3 SEC Form 4 filings across 1 company in the last 90 days.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | CCCC | C4 Therapeutics, Inc. | A — Grant or award | 2.6K | $4.34 | $12K |
| 2026-06-04 | CCCC | C4 Therapeutics, Inc. | M — Option exercise | 1.1K | $2.11 | $2K |
| 2026-04-03 | CCCC | C4 Therapeutics, Inc. | A — Grant or award | 4.3K | $2.70 | $11K |
| 2025-10-01 | CCCC | C4 Therapeutics, Inc. | A — Grant or award | 5.3K | $2.15 | $12K |
| 2025-07-01 | CCCC | C4 Therapeutics, Inc. | A — Grant or award | 7.6K | $1.51 | $12K |
| 2024-10-02 | CCCC | C4 Therapeutics, Inc. | A — Grant or award | 2.0K | $5.56 | $11K |
Anderson Kenneth Carl is a corporate insider — currently tracked as Director of C4 Therapeutics, Inc. (CCCC). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Anderson Kenneth Carl profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.